These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 33856036)

  • 21. Mapping the Functional Independence Measure to a multi-attribute utility instrument for economic evaluations in rehabilitation: a secondary analysis of randomized controlled trial data.
    Peiris CL; Taylor NF; Watts JJ; Shields N; Brusco NK; Mortimer D
    Disabil Rehabil; 2020 Oct; 42(21):3024-3032. PubMed ID: 30907143
    [No Abstract]   [Full Text] [Related]  

  • 22. A cost analysis of the first year after stroke - early triage and inpatient rehabilitation may reduce long term costs.
    Mahler MP; Züger K; Kaspar K; Haefeli A; Jenni W; Leniger T; Beer JH
    Swiss Med Wkly; 2008 Aug; 138(31-32):459-65. PubMed ID: 18690559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intervention study shows outpatient cardiac rehabilitation to be economically at least as attractive as inpatient rehabilitation.
    Schweikert B; Hahmann H; Steinacker JM; Imhof A; Muche R; Koenig W; Liu Y; Leidl R
    Clin Res Cardiol; 2009 Dec; 98(12):787-95. PubMed ID: 19821135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quality of life after hip, vertebral, and distal forearm fragility fractures measured using the EQ-5D-3L, EQ-VAS, and time-trade-off: results from the ICUROS.
    Svedbom A; Borgström F; Hernlund E; Ström O; Alekna V; Bianchi ML; Clark P; Curiel MD; Dimai HP; Jürisson M; Uusküla A; Lember M; Kallikorm R; Lesnyak O; McCloskey E; Ershova O; Sanders KM; Silverman S; Tamulaitiene M; Thomas T; Tosteson ANA; Jönsson B; Kanis JA
    Qual Life Res; 2018 Mar; 27(3):707-716. PubMed ID: 29235059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparing responsiveness of the EQ-5D-5L, EQ-5D-3L and EQ VAS in stroke patients.
    Golicki D; Niewada M; Karlińska A; Buczek J; Kobayashi A; Janssen MF; Pickard AS
    Qual Life Res; 2015 Jun; 24(6):1555-63. PubMed ID: 25425288
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estimation of minimally important differences in the EQ-5D and SF-6D indices and their utility in stroke.
    Kim SK; Kim SH; Jo MW; Lee SI
    Health Qual Life Outcomes; 2015 Mar; 13():32. PubMed ID: 25889191
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost and quality of life in patients with severe chronic hand eczema refractory to standard therapy with topical potent corticosteroids.
    Cortesi PA; Scalone L; Belisari A; Bonamonte D; Cannavò SP; Cristaudo A; De Pità O; Gallo R; Giannetti A; Gola M; Pigatto PD; Mantovani LG
    Contact Dermatitis; 2014 Mar; 70(3):158-68. PubMed ID: 24102212
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rehabilitation of older patients: day hospital compared with rehabilitation at home. A randomised controlled trial.
    Parker SG; Oliver P; Pennington M; Bond J; Jagger C; Enderby PM; Curless R; Chater T; Vanoli A; Fryer K; Cooper C; Julious S; Donaldson C; Dyer C; Wynn T; John A; Ross D
    Health Technol Assess; 2009 Aug; 13(39):1-143, iii-iv. PubMed ID: 19712593
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased Relative Functional Gain and Improved Stroke Outcomes: A Linked Registry Study of the Impact of Rehabilitation.
    Mosalski S; Shiner CT; Lannin NA; Cadilhac DA; Faux SG; Kim J; Alexander T; Breen S; Nilsson M; Pollack M; Bernhardt J; Simmonds F; Dewey HM; Grimley R; Hillier S; Kilkenny MF
    J Stroke Cerebrovasc Dis; 2021 Oct; 30(10):106015. PubMed ID: 34340054
    [TBL] [Abstract][Full Text] [Related]  

  • 30. AbobotulinumtoxinA and rehabilitation vs rehabilitation alone in post-stroke spasticity: A cost-utility analysis.
    Lazzaro C; Baricich A; Picelli A; Caglioni PM; Ratti M; Santamato A
    J Rehabil Med; 2020 Feb; 52(2):. PubMed ID: 31820010
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Additional Saturday rehabilitation improves functional independence and quality of life and reduces length of stay: a randomized controlled trial.
    Peiris CL; Shields N; Brusco NK; Watts JJ; Taylor NF
    BMC Med; 2013 Sep; 11():198. PubMed ID: 24228854
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Economic costs and health-related quality of life for hand, foot and mouth disease (HFMD) patients in China.
    Zheng Y; Jit M; Wu JT; Yang J; Leung K; Liao Q; Yu H
    PLoS One; 2017; 12(9):e0184266. PubMed ID: 28934232
    [TBL] [Abstract][Full Text] [Related]  

  • 33. BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A.
    Shaw L; Rodgers H; Price C; van Wijck F; Shackley P; Steen N; Barnes M; Ford G; Graham L;
    Health Technol Assess; 2010 May; 14(26):1-113, iii-iv. PubMed ID: 20515600
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Validity of the EQ-5D-5L and EQ-5D-3L in patients with Crohn's disease.
    Rencz F; Lakatos PL; Gulácsi L; Brodszky V; Kürti Z; Lovas S; Banai J; Herszényi L; Cserni T; Molnár T; Péntek M; Palatka K
    Qual Life Res; 2019 Jan; 28(1):141-152. PubMed ID: 30225788
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison between EQ-5D-5L and PROMIS-10 to evaluate health-related quality of life 3 months after stroke: a cross-sectional multicenter study.
    DE Graaf JA; Visser-Meily JM; Schepers VP; Baars A; Kappelle LJ; Passier PE; Wermer MJ; DE Wit DC; Post MW
    Eur J Phys Rehabil Med; 2021 Jun; 57(3):337-346. PubMed ID: 33448750
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The social and economic burden of stroke survivors in Italy: a prospective, incidence-based, multi-centre cost of illness study.
    Fattore G; Torbica A; Susi A; Giovanni A; Benelli G; Gozzo M; Toso V
    BMC Neurol; 2012 Nov; 12():137. PubMed ID: 23150894
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multivariable Regression Model of the EuroQol 5-Dimension Questionnaire in Patients Seeking Outpatient Low Vision Rehabilitation.
    Malkin AG; Goldstein JE; Massof RW
    Ophthalmic Epidemiol; 2017 Jun; 24(3):174-180. PubMed ID: 28045563
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison of the EQ-5D-3L and ICECAP-O in an older post-acute patient population relative to the general population.
    Couzner L; Crotty M; Norman R; Ratcliffe J
    Appl Health Econ Health Policy; 2013 Aug; 11(4):415-25. PubMed ID: 23807538
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Social and economic costs and health-related quality of life in non-institutionalised patients with cystic fibrosis in the United Kingdom.
    Angelis A; Kanavos P; López-Bastida J; Linertová R; Nicod E; Serrano-Aguilar P;
    BMC Health Serv Res; 2015 Sep; 15():428. PubMed ID: 26416027
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [EuroQol-5D FOR quality of life assessment in cardiac rehabilitation].
    Balestroni G; Omarini G; Omarini P; Zotti AM
    G Ital Med Lav Ergon; 2007; 29(3 Suppl B):B56-62. PubMed ID: 18575359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.